
Genetic markers could predict GLP-1 efficacy, data shows
Genetic biomarkers could predict GLP-1 efficacy response, results show. Human omics company Ovation.io and precision medicine company PrecisionLife have released findings from the first phase of their collaboration, showing biomarkers can predict the efficacy, safety and tolerability of GLP-1 therapies. Using Ovation’s longitudinal clinical and… Read More















